Skip to main content
OpenTrials

Clinical trial condition

Heredodegenerative Disorders, Nervous System

Explore clinical trials studying Heredodegenerative Disorders, Nervous System. Study availability and eligibility vary by location and protocol.

1,877 public trials 411 recruiting studies
Refine in advanced search Browse all conditions

Heredodegenerative Disorders, Nervous System trial results

Recruiting

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

NCT06463028

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +31 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of California, San Francisco (UCSF) San Francisco, California, United States
  • Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
  • Florida Cancer Specialists, North St. Petersburg, Florida, United States
View all 18 locations
View Trial Details
Recruiting

ESIS in Pediatric DRE

NCT05469373

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital Abnormalities, +16 more
Locations
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Recruiting

Validating Innovative Biosensors for Rett Autonomic Symptom Tracking

NCT06338267

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Genetic Diseases, X-Linked, +7 more
Locations
  • Rush University Medical Center Chicago, Illinois, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Baylor College of Medicine Houston, Texas, United States
View Trial Details
Recruiting

RASopathy Biorepository

NCT04395495

Conditions
Abnormalities, Multiple, Cardiofaciocutaneous Syndrome, Cardiofaciocutaneous syndrome, +48 more
Locations
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Recruiting

A First-in-Human, Open-Label, Dose-Escalation Study to Evaluate the Safety and Tolerability of Gene Therapy With TTX-381 for the Ocular Manifestations Associated With Neuronal Ceroid Lipofuscinosis Type 2 (CLN2) Disease

NCT05791864

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +10 more
Locations
  • University Medical Center Hamburg-Eppendorf (UKE)- Childrens Hospital Hamburg, Germany
  • Greater Ormond Street Hospital London, United Kingdom
View Trial Details
Recruiting

Oral Health and Wilson's Disease: SOMAWI

NCT05444127

Conditions
Basal Ganglia Diseases, Brain Diseases, Brain Diseases, Metabolic, +16 more
Locations
  • Hopital Charles Foix Ivry-sur-Seine, France
  • Hôpital Charles Foix Ivry-sur-Seine, France
  • Fondation Adolphe de Rothschild Paris, France
View Trial Details

Related conditions